Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.7888
-0.0112 (-1.40%)
At close: Aug 10, 2026, 4:00 PM EDT
0.8220
+0.0332 (4.21%)
After-hours: Aug 10, 2026, 7:37 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Medical Products
85.33M91.01M106.34M--
Proteomics
---52.50M67.66M
Genomics
---45.45M62.92M
Total
85.33M91.01M106.34M97.95M130.58M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Europe, Middle East and Africa (EMEA)
---33.14M42.72M
Americas Excl. United States
2.16M2.00M2.10M2.98M3.68M
Emea Excl. Sweden
27.39M26.55M29.82M--
Sweden
8.60M9.10M6.38M--
United States
28.40M35.40M44.10M41.00M60.20M
Asia-Pacific (Excl. China)
7.88M7.95M7.99M10.06M11.48M
China
10.90M10.01M15.95M10.77M12.50M
Total
85.33M91.01M106.34M97.95M130.58M